OCCIDENT
Investor profile
Venture capital
OCCIDENT has backed 16 European tech companies across 20 funding rounds between 2016 and 2026, joining rounds totalling €496M. Most active in Healthtech and Software. Data as of Nov 2026.
Also recorded as: Occident Group
Deals
20
distinct rounds
Companies
16
backed
Active span
2016–2026
11 yrs
Total round €
€496M
sum of rounds joined
Deals by year
distinct rounds / yearOCCIDENT — deals by year — interactive chart.
Data table
| OCCIDENT — deals by year | |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Top sectors
by dealsOCCIDENT — top sectors — interactive chart.
Data table
| OCCIDENT — top sectors | |
|---|---|
| Healthtech | 16 |
| Software | 1 |
| Deeptech | 1 |
| Energy | 1 |
| Cybersecurity | 1 |
| Semiconductors | 1 |
Stages
by dealsOCCIDENT — stages — interactive chart.
Data table
| OCCIDENT — stages | |
|---|---|
| Other | 6 |
| Series A | 5 |
| Series B | 4 |
| Seed | 3 |
| Series C | 1 |
| Series D+ | 1 |
Countries
by dealsOCCIDENT — countries — interactive chart.
Data table
| OCCIDENT — countries | |
|---|---|
| Switzerland | 12 |
| Germany | 6 |
| Finland | 1 |
| Slovenia | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- High-Tech Gründerfonds (HTGF)7
- Zürcher Kantonalbank6
- Bayern Kapital3
- Andera Partners2
- FundPlus2
- Seventure Partners2
- another.vc1
- Arve Capital1
- Ascenta Capital1
- BackBone Ventures1
- Beteiligungs-Managementgesellschaft Hessen (BMH)1
- BHS Corrugated1
- BioMedPartners1
- bm-t Beteiligungsmanagement Thüringen GmbH1
- CDP Venture Capital's Digital Transition Fund1
- Coparion1
- Deep Track Capital1
- Dr. Tine Tomažič1
- EGSB1
- EIC Fund1
- EQT Life Sciences1
- ETH Foundation1
- Evotec1
- Fongit1
- Frazier Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Lunaphore Technologies | Switzerland | 2 | €45M |
| Lymphatica Medtech | Switzerland | 1 | €18M |
| Code Intelligence | Germany | 1 | €12M |
| resistell | Switzerland | 2 | €12M |
| Hemotune AG | Switzerland | 1 | €7.1M |
| Resistell Ag | Switzerland | 2 | €6.5M |
| Altavo | Germany | 1 | €5.0M |
| hemotune | Switzerland | 1 | €4.7M |
| core sensing | Germany | 1 | €4.5M |
| Invasight | Switzerland | 1 | €4.3M |
| ImmitraBio | Switzerland | 1 | €2.6M |
| Chipmetrics | Finland | 1 | €2.4M |
| Avelo | Switzerland | 1 | €2.3M |
| ReCatalyst | Slovenia | 1 | €1.7M |
| Cunesoft | Germany | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Lunaphore Technologies | Series D+ | €40M | 2023-03 |
| Lymphatica Medtech | Other | €18M | 2024-10 |
| Code Intelligence | Other | €12M | 2022-06 |
| resistell | Series B | €8.6M | 2022-12 |
| Hemotune AG | Series B | €7.1M | 2022-04 |
| Altavo | Series A | €5.0M | 2024-02 |
| hemotune | Series A | €4.7M | 2020-08 |
| Lunaphore Technologies | Series B | €4.7M | 2018-08 |